Bisphosphonates for advanced prostate cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Bisphosphonates for Advanced Prostate Cancer." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434135/all/Bisphosphonates_for_advanced_prostate_cancer. 
Bisphosphonates for advanced prostate cancer. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434135/all/Bisphosphonates_for_advanced_prostate_cancer. Accessed October 31, 2025.
Bisphosphonates for advanced prostate cancer. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434135/all/Bisphosphonates_for_advanced_prostate_cancer
Bisphosphonates for Advanced Prostate Cancer [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 October 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434135/all/Bisphosphonates_for_advanced_prostate_cancer.
* Article titles in AMA citation format should be in sentence-case
TY  -  ELEC
T1  -  Bisphosphonates for advanced prostate cancer
ID  -  434135
BT  -  Cochrane Abstracts
UR  -  https://evidence.unboundmedicine.com/evidence/view/Cochrane/434135/all/Bisphosphonates_for_advanced_prostate_cancer
PB  -  John Wiley & Sons, Inc
DB  -  Evidence Central
DP  -  Unbound Medicine
ER  -  

 Cochrane Abstracts
Cochrane Abstracts

